1. Home
  2. GRFS vs PNFP Comparison

GRFS vs PNFP Comparison

Compare GRFS & PNFP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GRFS
  • PNFP
  • Stock Information
  • Founded
  • GRFS 1940
  • PNFP 2000
  • Country
  • GRFS Spain
  • PNFP United States
  • Employees
  • GRFS N/A
  • PNFP N/A
  • Industry
  • GRFS Biotechnology: Pharmaceutical Preparations
  • PNFP Major Banks
  • Sector
  • GRFS Health Care
  • PNFP Finance
  • Exchange
  • GRFS Nasdaq
  • PNFP Nasdaq
  • Market Cap
  • GRFS 6.6B
  • PNFP 6.6B
  • IPO Year
  • GRFS 2006
  • PNFP N/A
  • Fundamental
  • Price
  • GRFS $9.11
  • PNFP $85.72
  • Analyst Decision
  • GRFS Hold
  • PNFP Buy
  • Analyst Count
  • GRFS 1
  • PNFP 13
  • Target Price
  • GRFS $10.30
  • PNFP $113.67
  • AVG Volume (30 Days)
  • GRFS 592.2K
  • PNFP 1.2M
  • Earning Date
  • GRFS 01-01-0001
  • PNFP 10-15-2025
  • Dividend Yield
  • GRFS 1.58%
  • PNFP 1.12%
  • EPS Growth
  • GRFS 132.60
  • PNFP 49.26
  • EPS
  • GRFS 0.53
  • PNFP 7.83
  • Revenue
  • GRFS $8,744,226,659.00
  • PNFP $1,885,186,000.00
  • Revenue This Year
  • GRFS $5.46
  • PNFP $31.11
  • Revenue Next Year
  • GRFS $6.69
  • PNFP $119.44
  • P/E Ratio
  • GRFS $22.60
  • PNFP $10.95
  • Revenue Growth
  • GRFS 9.32
  • PNFP 21.58
  • 52 Week Low
  • GRFS $6.19
  • PNFP $81.57
  • 52 Week High
  • GRFS $11.14
  • PNFP $131.91
  • Technical
  • Relative Strength Index (RSI)
  • GRFS 36.85
  • PNFP 40.29
  • Support Level
  • GRFS $9.14
  • PNFP $83.60
  • Resistance Level
  • GRFS $9.50
  • PNFP $86.05
  • Average True Range (ATR)
  • GRFS 0.29
  • PNFP 2.29
  • MACD
  • GRFS -0.02
  • PNFP 0.02
  • Stochastic Oscillator
  • GRFS 26.39
  • PNFP 28.58

About GRFS Grifols S.A.

Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.

About PNFP Pinnacle Financial Partners Inc.

Pinnacle Financial Partners Inc is a financial holding company. The company operates through its wholly-owned subsidiary, Pinnacle Bank. The bank provides a full range of lending products, including commercial, real estate, and consumer loans to individuals and small to medium-sized businesses. It operates as a community bank mainly in the urban markets of Nashville, Knoxville, Memphis, and Chattanooga, Tennessee, as well as surrounding counties. It relies heavily on mergers and acquisitions. A majority of its loan portfolio is in commercial loans, mainly real estate, as well as industrial loans. The bank generates a majority of its net revenue through net interest income.

Share on Social Networks: